Jeffrey Hackman
Chief Executive Officer at Comera Life Sciences, Inc.
Net worth: 1 095 $ as of 2024-05-30
Network origin in Jeffrey Hackman first degree
Entity | Entity type | Industry | |
---|---|---|---|
Extinct | Pharmaceuticals: Major | 14 | |
Public Company | Pharmaceuticals: Major | 11 | |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jeffrey Hackman via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
Broadfin Healthcare Fund LP
Broadfin Healthcare Fund LP Investment ManagersFinance Broadfin Healthcare Fund LP provides healthcare funding services. Broadfin Advisors LLC is the general partner of the company. The company is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
Broadfin Healthcare Offshore Fund Ltd.
Broadfin Healthcare Offshore Fund Ltd. Investment Banks/BrokersFinance Broadfin Healthcare Offshore Fund Ltd. invests and trades securities and other financial instruments. The company is headquartered in George Town, Cayman Islands. | Investment Banks/Brokers | Director/Board Member | |
SeaStar Medical, Inc.
SeaStar Medical, Inc. Information Technology ServicesTechnology Services Seastar Medical, Inc. manufactures and supplies medical devices. It offers medical device that cures inflammation-based diseases and conditions. The company was founded by James P. Sherblom in July 2007 and is headquartered in Denver, CO. | Information Technology Services | Founder | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
University of Virginia | College/University | Undergraduate Degree Doctorate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
University of California, Santa Barbara | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal | |
Broadfin Capital LLC
Broadfin Capital LLC Investment ManagersFinance Broadfin Capital LLC (Broadfin) is an independent hedge fund manager headquartered in New York City. The firm was founded by Kevin Kotler in 2005. Through the funds they advise, the firm may provide investment management services to individuals, investment companies, pooled investment vehicles, pension and profit sharing plans, trusts, estates, governmental plans, endowments, foundations, charitable organizations, corporations, insurance companies, limited partnerships, commingled investment trusts, and other entities. | Investment Managers | Chief Executive Officer | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Founder | |
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Crop Enhancement LLC
Crop Enhancement LLC Chemicals: AgriculturalProcess Industries Crop Enhancement LLC develops green formulation technologies for improving agricultural production. It offers three environmental products platform: CropCoat Produce Protection, Agrochemical Encapsulatio, and Particle Stabilization. The company was founded by David Soane and Zach Jonasson in 2011 and is headquartered in Cambridge, MA. | Chemicals: Agricultural | Founder Chief Tech/Sci/R&D Officer | |
REVO BIOLOGICS INC | Biotechnology | Director/Board Member Chief Executive Officer | |
UCSF School of Medicine | College/University | Doctorate Degree | |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
ABSCI CORPORATION | Biotechnology | Director/Board Member Director of Finance/CFO | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
VAXART, INC. | Biotechnology | Director/Board Member Director/Board Member | |
OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Chief Executive Officer |
Statistics
International
United States | 47 |
Canada | 3 |
Ireland | 2 |
Cayman Islands | 2 |
Sectoral
Health Technology | 30 |
Finance | 8 |
Consumer Services | 6 |
Commercial Services | 4 |
Technology Services | 4 |
Operational
Director/Board Member | 194 |
Independent Dir/Board Member | 80 |
Corporate Officer/Principal | 69 |
Chief Executive Officer | 34 |
Undergraduate Degree | 27 |
Most connected contacts
Insiders | |
---|---|
Mark Corrigan | 29 |
Zachariah Jonasson | 25 |
Anne VanLent | 23 |
V. Lawlis | 21 |
Geoffrey F. Cox | 20 |
Sandy Smith | 19 |
Stuart Randle | 19 |
Mary Szela | 19 |
Suzanne Bruhn | 18 |
Jason Aryeh | 18 |
Gregory Perry | 16 |
Sirshendu Roopom Banerjee | 16 |
Barbara Finck | 15 |
James Sherblom | 14 |
Kevin Kotler | 14 |
- Stock Market
- Insiders
- Jeffrey Hackman
- Company connections